Arrowhead Pharmaceuticals, Inc. (ARWR) vs Cytokinetics, Incorporated (CYTK)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Cytokinetics, Incorporated CYTK 61.95 −3.08%
Arrowhead Pharmaceuticals, Inc. and Cytokinetics, Incorporated are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Cytokinetics, Incorporated are of similar size ($8.9B and $8.3B). Arrowhead Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 16.1% against −21.1%. Arrowhead Pharmaceuticals, Inc. has the higher net margin (−47.8% vs −1,321.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 13 and Cytokinetics, Incorporated on 3.
Valuation
Profitability
| Metric | ARWR | CYTK | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 87.97% | 65.16% |
| Operating margin | (33.82%) | (1,046.12%) | 0.00% |
| Net margin | (47.79%) | (1,321.12%) | 0.00% |
| Free cash flow margin | (11.22%) | (858.16%) | 0.00% |
| Return on equity | (64.91%) | 329.76% | (56.36%) |
| Return on assets | (18.32%) | (56.76%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack